Galectin-3 and oncofetal-fibronectin expression in thyroid neoplasia as assessed by reverse transcription-polymerase chain reaction and immunochemistry in cytologic and pathologic specimens

Thyroid

Volumn 13, Issue 8, 2003, Pages 765-770

  Giannini, Riccardo ^a   Faviana, Pinuccia ^a   Cavinato, Tiziana ^a   Elisei, Rossella ^a   Pacini, Furio ^b   Berti, Piero ^a   Fontanini, Gabriella ^a   Ugolini, Clara ^a   Camacci, Tiziano ^a   De Ieso, Katia ^a   Miccoli, Paolo ^a   Pinchera, Aldo ^a   Basolo, Fulvio ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; GALECTIN 3; ONCOFETAL FIBRONECTIN; UNCLASSIFIED DRUG;

ARTICLE; ASPIRATION BIOPSY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID ADENOMA; THYROID PAPILLARY CARCINOMA;

EID: 10744224975     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/105072503768499662     Document Type: Article

References (40)

1. Silverman JF, West RL, Larkin EW, Park HK, Finley JL, Swanson MS, Fore WW 1986 The role of fine-needle aspiration biopsy in the rapid diagnosis and management of thyroid neoplasm. Cancer 57:1164-1170.
2. Nunez C, Mendelsohn G 1989 Fine-needle aspiration and needle biopsy of the thyroid gland. Pathol Annu 24:161-198.
3. Hall TL, Layfield LJ, Philippe A, Rosenthal DL 1989 Sources of diagnostic error in fine needle aspiration of the thyroid. Cancer 63:718-725.
4. Caraway NP, Sneige N, Samaan NA 1993 Diagnostic pitfalls in thyroid fine-needle aspiration: A review of 394 cases. Diagn Cytopathol 9:345-350.
5. Sidawy MK, Del Vecchio DM, Knoll SM 1997 Fine-needle aspiration of thyroid nodules: Correlation between cytology and histology and evaluation of discrepant cases. Cancer 81:253-259.
6. Baloch ZW, Sack MJ, Yu GH, Livolsi VA, Gupta PK 1998 Fine-needle aspiration of thyroid: An institutional experience. Thyroid 8:565-569.
7. Bartolazzi A 2000 Improving accuracy of cytology for nodular thyroid lesions. Lancet 355:1661-1662.
8. Westermark K, Lundqvist M, Wallin G, Dahlman T, Hacker GW, Heldin NE, Grimelius L 1996 EGF-receptors in human normal and pathological thyroid tissue. Histopathology 28:221-227.
9. Soda G, Antonaci A, Bosco D, Nardoni S, Melis M 1999 Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas. J Exp Clin Cancer Res 18:363-367.
10. Utrilla JC, Martin-Lacave I, San Martin MV, Fernandez-Santos JM, Galera-Davidson H 1999 Expression of c-erbB-2 oncoprotein in human thyroid tumours. Histopathology 34:60-65.
11. Vella V, Sciacca L, Pandini G, Mineo R, Squatrito S, Vigneri R, Belfiore A 2001 The IGF system in thyroid cancer: New concepts. Mol Pathol 54:121-124.
12. Hosal SA, Apel RL, Freeman JL, Azadian A, Rosen IB, LiVolsi VA, Asa SL 1997 Immunohistochemical localization of p53 in human thyroid neoplasms: Correlation with biological behavior. Endocr Pathol 8:21-28.
13. Gonzalez-Campora R, Galera-Ruiz D, Armas-Padron JR, Otal-Salaverri C, Galera-Davidson H 1998 Dipeptidyl aminopeptidase IV in the cytologic diagnosis of thyroid carcinoma. Diagn Cytopathol 19:4-8.
14. Fluge O, Haugen DR, Lillehaug JR, Varhaug JE 2001 Difference in patterns of Met expression in papillary thyroid carcinomas and nonneoplastic thyroid tissue. World J Surg 25:623-631.
15. Takano T, Sumizaki H, Nakano K, Matsuzuka F, Kuma K, Amino N 1996 Increased expression of CD44 variants in differentiated thyroid cancers. Jpn J Cancer Res 87:1245-1250.
16. Takano T, Matsuzuka F, Sumizaki H, Kuma K, Amino N 1997 Rapid detection of specific messenger RNAs in thyroid carcinomas by reverse transcription-PCR with degenerate primers: Specific expression of oncofetal fibronectin messenger RNA in papillary carcinoma. Cancer Res 57:3792-3797.
17. Fernandez PL, Merino MJ, Gomez M, Campo E, Medina T, Castronovo V, Sanjuan X, Cardesa A, Liu FT, Sobel ME 1997 Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue. J Pathol 181:80-86.
18. Ruoslahti E 1988 Structure and biology of proteoglycans. Annu Rev Cell Biol 4:229-255.
19. Carnemolla B, Balza E, Siri A, Zardi L, Nicotra MR, Bigotti A, Natali PG 1989 A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors. J Cell Biol 108:1139-1148.
20. Takano T, Matsuzuka F, Miyauchi A, Yokozawa T, Liu G, Morita S, Kuma K, Amino N 1998 Restricted expression of oncofetal fibronectin mRNA in thyroid papillary and anaplastic carcinoma: An in situ hybridization study. Br J Cancer 78:221-224.
21. Barondes SH, Cooper DN, Gitt MA, Leffier H 1994 Galectins. Structure and function of a large family of animal lectins. J Biol Chem 269:20807-20810.
22. Raz A, Lotan R. 1987 Endogenous galactoside-binding lectins: A new class of functional tumor cell surface molecules related to metastasis. Cancer Metastasis Rev 6:433-452.
23. Lotan R, Ito H, Yasui W, Yokozaki H, Lotan D, Tahara E 1994 Expression of a 31-kDa lactoside-binding lectin in normal human gastric mucosa and in primary and metastatic gastric carcinomas. Int J Cancer 56:474-480.
24. Nakamura M, Inufusa H, Adachi T, Aga M, Kurimoto M, Nakatani Y, Wakano T, Nakajima A, Hida JI, Miyake M, Shindo K, Yasutomi M 1999 Involvement of galectin-3 expression in colorectal cancer progression and metastasis. Int J Oncol 15:143-148.
25. Bresalier RS, Yan PS, Byrd JC, Lotan R, Raz A 1997 Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system. Cancer 80:776-787.
26. Cvejic D, Savin S, Paunovic I, Tatic S, Havelka M, Sinadinovic J 1998 Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue. Anticancer Res 18:2637-2641.
27. Orlandi F, Saggiorato E, Pivano G, Puligheddu B, Termine A, Cappia S, De Giuli P, Angeli A 1998 Galectin-3 is a presurgical marker of human thyroid carcinoma. Cancer Res 58:3015-3020.
28. Cvejic D, Savin S, Golubovic S, Paunovic I, Tatic S, Havelka M 2000 Galectin-3 and carcinoembryonic antigen expression in medullary thyroid carcinoma: Possible relation to tumour progression. Histopathology 37:530-535.
29. Takano T, Miyauchi A, Yokozawa T, Matsuzuka F, Liu G, Higashiyama T, Morita S, Kuma K, Amino N 1998 Accurate and objective preoperative diagnosis of thyroid papillary carcinomas by reverse transcription-PCR detection of oncofetal fibronectin messenger RNA in fine-needle aspiration biopsies. Cancer Res 58:4913-4917.
30. Takano T, Miyauchi A, Yokozawa T, Matsuzuka F, Maeda I, Kuma K, Amino N 1999 Preoperative diagnosis of thyroid papillary and anaplastic carcinomas by real-time quantitative reverse transcription-polymerase chain reaction of oncofetal fibronectin messenger RNA. Cancer Res 59: 4542-4545.
31. Higashiyama T, Takano T, Matsuzuka F, Liu G, Miyauchi A, Yokozawa T, Morita S, Kuma K, Shiba E, Noguchi S, Amino N 1999 Measurement of the expression of oncofetal fibronectin mRNA in thyroid carcinomas by competitive reverse transcription-polymerase chain reaction. Thyroid 9:235-240.
32. Takano T, Shiba E, Tada H, Yoshimura H, Yoshida K, Doi R, Amino N 2000 Preoperative diagnosis of thyroid carcinomas by aspiration biopsy-reverse transcription-polymerase chain reaction (ABRP): A report of two cases. Endocr J 47:271-275.
33. Inohara H, Honjo Y, Yoshii T, Akahani S, Yoshida J, Hattori K, Okamoto S, Sawada T, Raz A, Kubo T 1999 Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Cancer 85:2475-2484.
34. Herrmann ME, LiVolsi VA, Pasha TL, Roberts SA, Wojcik EM, Baloch ZW 2002 Immunohistochemical expression of galectin-3 in benign and malignant thyroid lesions. Arch Pathol Lab Med 126:710-713.
35. Gasbarri A, Martegani MP, Del Prete F, Lucante T, Natali PG, Bartolazzi A 1999 Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules. J Clin Oncol 17:3494-3502.
36. Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A, Inohara H, Marandino F, Orlandi F, Nardi F, Vecchione A, Tecce R, Larsson O, Thyroid Cancer Study Group 2001 Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 357:1644-1650.
37. Saggiorato E, Cappia S, De Giuli P, Mussa A, Pancani G, Caraci P, Angeli A, Orlandi F 2001 Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma. J Clin Endocrinol Metab 86:5152-5158.
38. Aratake Y, Umeki K, Kiyoyama K, Hinoura Y, Sato S, Ohno A, Kuribayashi T, Hirai K, Nabeshima K, Kotani T 2002 Diagnostic utility of galectin-3 and CD26/DPPIV as preoperative diagnostic markers for thyroid nodules. Diagn Cytopathol 26:366-372.
39. Papotti M, Volante M, Saggiorato E, Deandreis D, Veltri A, Orlandi F 2001 Role of galectin-3 immunodetection in the cytological diagnosis of thyroid cystic papillary carcinoma. Eur J Endocrinol 147:515-521.
40. Kawachi K, Matsushita Y, Yonezawa S, Nakano S, Shirao K, Natsugoe S, Sueyoshi K, Aikou T, Sato E 2000 Galectin-3 expression in variou thyroid neoplasms and its possible role in metastasis formation. Hum Pathol 31:428-433.